Resources Contact Us Home
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies

Image Number 12 for United States Patent #7491393.

The present invention relates to the identification of antibodies which are specific to human B7.1 antigen (CD80) and which are capable of inhibiting the binding of B7.1 to a CD28 receptor and which are not capable of inhibiting the binding of B7.1 to a CTLA-4 receptor. Two of these antibodies, 16C10 and 7C10, significantly inhibit the production of IL-2, in spite of the existence of a second activating ligand B7.2 (CD86). Blocking of the primary activation signal between CD28 and B7.1 (CD80) with these antibodies while allowing the unimpaired or coincident interaction of CTLA-4 and B7.1 and/or B7.2 represents a combined antagonistic effect on positive co-stimulation with an agonistic effect on negative signalling. These antibodies may be used as specific immunosuppressants, e.g., for the treatment of autoimmune diseases and to prevent organ transplant rejection.

  Recently Added Patents
Thermochromic microparticles, dispersions thereof, and manufacturing method thereof, as well as light-modulating coatings, light-modulating films and light-modulating inks
Multilevel directory assistance apparatus and method
Optical article comprising a temporary anti-fogging coating with improved durability
Sabatier process and apparatus for controlling exothermic reaction
Hand sign
Systems and methods for economic retirement analysis
Image forming apparatus with enhanced display of guidance information
  Randomly Featured Patents
Compound semiconductor device, production method of compound semiconductor device and diode
Belt tensioning device
Method for treating hazardous waste
Dehumidifying radome vent
Feed additive for ruminants
Allocation of space in an immersive environment
Weighted service cloth
Storage system
Method of voltage controlled oscillator digital/analog converted value adjustment of compact disk read only memory device
Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP)